UK Markets close in 38 mins

CureVac N.V. (CVAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.25+0.31 (+3.90%)
As of 10:50AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 350.09
52-week low 36.99
50-day moving average 310.96
200-day moving average 317.12

Share statistics

Avg vol (3-month) 3393.26k
Avg vol (10-day) 3445.09k
Shares outstanding 5187.05M
Implied shares outstanding 6N/A
Float 884.4M
% held by insiders 152.57%
% held by institutions 124.13%
Shares short (14 Jul 2022) 43.13M
Short ratio (14 Jul 2022) 43.69
Short % of float (14 Jul 2022) 44.35%
Short % of shares outstanding (14 Jul 2022) 41.67%
Shares short (prior month 14 Jun 2022) 45.59M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin -266.86%
Operating margin (ttm)-822.89%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)-45.17%

Income statement

Revenue (ttm)117.33M
Revenue per share (ttm)0.63
Quarterly revenue growth (yoy)143.00%
Gross profit (ttm)-135.09M
EBITDA -953.85M
Net income avi to common (ttm)-313.11M
Diluted EPS (ttm)-2.87
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)658.2M
Total cash per share (mrq)3.52
Total debt (mrq)40.66M
Total debt/equity (mrq)6.03
Current ratio (mrq)3.32
Book value per share (mrq)3.72

Cash flow statement

Operating cash flow (ttm)-673.13M
Levered free cash flow (ttm)N/A